EUROPEAN NETWORK of FIBROMYALGIA ASSOCIATIONS

The European Medicines Agency (EMEA) are to have a consultation with a delegation from the European Network of Fibromyalgia Associations (ENFA)

PIERRE FABRE MEDICAMENT AND FOREST LABORATORIES TO COLLABORATE ON DEVELOPMENT AND COMMERCIALIZATION

Collaboration to develop proprietory selection norepinephrine and serotonin reuptake inhibitor for depression and central nervous system disorders.

Unique pattern of gene expression can indicate acetaminophen overdose

Contact: Robin Mackar rmackar@niehs.nih.gov 919-541-0073 NIH/National Institute of Environmental Health Sciences May lead to new tool for physicians In a new study, researchers found they could detect toxic levels of acetaminophen in laboratory animals by analyzing gene expression in the blood. This study by the National Institute of Environmental Health Sciences (NIEHS), part of the [...]

Team Up to Fight Arthritis

FOR IMMEDIATE PRESS RELEASE August 6, 2007 through September 22, 2007 Unifour Arthritis Walk¾ The Arthritis Foundation is seeking walkers of all ages to form individual or group teams for the Arthritis Walk. The Arthritis Foundation’s annual nationwide event that raises awareness and funds to fight arthritis, the nation’s number one cause of disability. Did [...]

Opioids for managing chronic non-malignant pain: safe and effective prescribing.

Kahan M, Srivastava A, Wilson L, Mailis-Gagnon A, Midmer D. Addiction Medical Service, St Joseph’s Health Centre, Toronto, Ontario, Canada. kahanm@stjoe.on.ca OBJECTIVE: To review the evidence on safe and effective prescribing of opioids for chronic non-malignant pain. QUALITY OF EVIDENCE: MEDLINE was searched using the terms “opioid effectiveness” and “adverse effects.” There is strong evidence [...]

Prevalence of Interpersonal Abuse in Primary Care Patients Prescribed Opioids for Chronic Pain.

Balousek S, Plane MB, Fleming M. Department of Family Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA. BACKGROUND: Interpersonal abuse is associated with clinical problems including chronic pain disorders. OBJECTIVES: The objective of this study is to describe 30-day and lifetime prevalence of emotional, physical, and sexual abuse found in [...]

SOUNDING OFF ABOUT FIBROMYALGIA AWARENESS WEEK

By Jeanne Hambleton© UK Fibromite I know I am always going on about raising awareness and fibromyalgia and this is especially important as far as the UK Government is concerned. Although we have E Petitions allegedly for the eyes of the Prime Minister, asking for support for various aspects of fibromyalgia, I have my doubts [...]

The classification of fibromyalgia syndrome.

Müller W, Schneider EM, Stratz T. Rheumatologische Forschungsabteilung, Weihermatten 1, 79713, Bad Säckingen, Germany. As has been shown by a number of working groups, primary fibromyalgia syndrome does not represent a single clinical entity. It is possible to distinguish between a subgroup with high pain sensitivity and no associated psychiatric condition, a second and a [...]

Publication trends in chronic fatigue syndrome: Comparisons with fibromyalgia and fatigue: 1995-2004.

Friedberg F, Sohl S, Schmeizer B. Department of Psychiatry and Behavioral Medicine, Stony Brook University, NY, USA. OBJECTIVE: In order to identify publishing patterns in chronic fatigue syndrome (CFS), we compared the annual number of peer review articles for CFS, fibromyalgia (FM), and non-CFS fatigue over a recent decade (1995-2004). METHOD: Citations were drawn from [...]

Characteristics and healthcare costs of patients with fibromyalgia syndrome.

Berger A, Dukes E, Martin S, Edelsberg J, Oster G. Policy Analysis, Inc. (PAI), Brookline, MA, USA. Purpose: To examine the characteristics and healthcare costs of fibromyalgia syndrome (FMS) patients in clinical practice. Materials and methods: Using a US health-insurance database, we identified all patients, aged >/= 18 years, with any healthcare encounters for FMS [...]